Trimedyne, Inc. reported financial results for the first quarter ended December 31, 2013. Revenues for the quarter ended December 31, 2013, were $1,399,000, a 5.2% decrease from revenues of $1,475,000 for the prior year's quarter. The company had a net loss of $259,000 or $0.014 per share for the current quarter, compared to a loss of $144,000 or $0.008 per share for the same quarter of the prior year, based on a weighted average of 18,395,960 shares outstanding.
1st Jan change | Capi. | |
---|---|---|
+4.64% | 208B | |
+8.99% | 182B | |
+29.83% | 155B | |
+35.17% | 115B | |
+2.55% | 66.52B | |
+15.06% | 53.93B | |
-6.47% | 46.26B | |
-2.14% | 38.22B | |
+6.88% | 36.6B |